Financial Data and Key Metrics Changes - The company reported full-year revenue growth of 6% to $6.3 billion, achieving its highest-ever revenue, EBITDA, and operating cash flow in 2025 [7][19] - Fourth quarter revenue was $1.61 billion, essentially flat year-over-year, with adjusted EBITDA of $134 million, which was 2% above the implied guidance midpoint [18][19] - Operating cash flow for 2025 was $471 million, up nearly 50% from the previous year, with a significant increase in cash reserves to over $710 million [6][21] Business Line Data and Key Metrics Changes - Admissions and adjusted admissions grew by 5.3% and 2.3% respectively for the full year 2025, with fourth quarter admissions increasing by 1.5% and adjusted admissions growing by 2% [7][18] - The company achieved a 9% growth in adjusted EBITDA for the full year, with margins expanding by 20 basis points to 8.6% [19] Market Data and Key Metrics Changes - The company’s markets are growing two to three times faster than the national average, supported by rising care complexity [14] - Payer denials in Q4 remained consistent with Q3, showing early signs of improvement, while professional fees growth decelerated to 8% from 11% in Q3 [12] Company Strategy and Development Direction - The company is focused on optimizing revenue, disciplined expense management, and productivity while delivering quality care [14] - The IMPACT program is a multi-year initiative aimed at improving margins, performance, and care transformation, with expected savings raised to approximately $55 million for 2026 [9][24] - The deployment of AI and technology is a key part of the company’s transformation strategy, enhancing operational efficiency and care delivery [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company’s performance and momentum heading into 2026, despite industry headwinds [6][14] - The company expects adjusted EBITDA guidance for 2026 to be between $485 million and $535 million, reflecting core earnings growth and IMPACT program savings [14][22] Other Important Information - The company strengthened its balance sheet during 2025, reducing lease-adjusted net leverage to 2.5x and total net leverage to 0.8x [21] - The company repurchased $3 million of stock during the fourth quarter, with $47 million remaining under its repurchase authorization [21] Q&A Session Summary Question: Professional fees increase in 2025 and expectations for 2026 - Professional fee growth in 2025 was in the high single-digit range, with similar assumptions for 2026 [31][32] Question: Expected volume declines in 2026 - The company is planning for a 20% decline in enrollment, with 10%-15% moving to employer-sponsored coverage and the rest going to self-pay [36][37] Question: Details on the $15 million increase in the IMPACT program - The majority of the $15 million increment identified is in the salaries, wages, and benefits line [38] Question: IMPACT initiatives with longer lead times - The IMPACT initiatives are designed to be multiyear and sustainable, with ongoing opportunities in supply chain and revenue cycle management [42] Question: Volume impact from winter storms - The primary impacts were in Texas and Oklahoma, with minimal expected impact on Q1 overall [45] Question: Cash flow growth in line with EBITDA - A $50 million headwind from payroll timing is expected, but cash flows are anticipated to follow consistent with the 2026 guidance [67] Question: Update on ambulatory or outpatient strategy - The company is expanding its urgent care and outpatient services, with several new facilities planned [65] Question: Length of stay and payer class variations - Length of stay is influenced by acuity and efficiency, with ongoing efforts to improve performance [91] Question: Impact of CMS waiver model and AI tools on denial rates - The company is not assuming significant changes in denial trends but is optimistic about technological advances aiding performance [93]
Ardent Health Partners, Inc.(ARDT) - 2025 Q4 - Earnings Call Transcript